Cognition Therapeutics Inc (CGTX)

Nov 28, 2025

Cognition Therapeutics Inc Stock Analysis and ForecastConsumer Goods Stocks & Affordable Market Investment - earlytimes.in

Nov 28, 2025

Nov 27, 2025

Cognition Therapeutics Inc. (CGTX) Stock Price | Live Quotes & Charts | NASDAQ - StocksToTrade

Nov 27, 2025

Nov 27, 2025

How Cognition Therapeutics Inc. stock reacts to oil pricesEarnings Recap Report & Free Real-Time Volume Trigger Notifications - moha.gov.vn

Nov 27, 2025

Nov 21, 2025

Cognition Therapeutics: A High-Stakes Bet On A Single DrugWhy I Hold (NASDAQ:CGTX) - Seeking Alpha

Nov 21, 2025

Nov 21, 2025

B. Riley Securities Reiterates Cognition Therapeutics (CGTX) Buy Recommendation - Nasdaq

Nov 21, 2025

Nov 21, 2025

Cognition Therapeutics (CGTX) Sees Analyst Price Target Boost | - GuruFocus

Nov 21, 2025

Nov 21, 2025

B. Riley Raises Price Target on Cognition Therapeutics to $3 From $2, Keeps Buy Rating - MarketScreener

Nov 21, 2025

Nov 20, 2025

Cognition Therapeutics to Participate in 37th Annual Piper Sandler Healthcare Conference - The Manila Times

Nov 20, 2025

Nov 20, 2025

Cognition Therapeutics, Inc. CEO Lisa Ricciardi to Speak at Annual Piper Sandler Healthcare Conference - Quiver Quantitative

Nov 20, 2025

Nov 20, 2025

Cognition Therapeutics (Nasdaq: CGTX) CEO Talk at 37th Piper Sandler Healthcare Conf - Stock Titan

Nov 20, 2025

Nov 20, 2025

Will Cognition Therapeutics Inc. stock beat EPS estimatesJuly 2025 PostEarnings & Safe Entry Trade Reports - newser.com

Nov 20, 2025

Nov 19, 2025

Can Cognition Therapeutics Inc. stock beat analyst upgradesEarnings Trend Report & AI Enhanced Trading Alerts - newser.com

Nov 19, 2025

Nov 19, 2025

What analyst consensus says on Cognition Therapeutics Inc. stock - newser.com

Nov 19, 2025

Nov 19, 2025

Will Cognition Therapeutics Inc. stock pay special dividendsPortfolio Performance Report & Long-Term Growth Portfolio Plans - newser.com

Nov 19, 2025

Nov 19, 2025

HC Wainwright & Co. Reiterates Cognition Therapeutics (CGTX) Buy Recommendation - Nasdaq

Nov 19, 2025

Nov 19, 2025

How to use a screener to detect Cognition Therapeutics Inc. breakoutsTrade Volume Summary & High Win Rate Trade Alerts - newser.com

Nov 19, 2025

Nov 18, 2025

Why Cognition Therapeutics Inc. stock appeals to dividend seekersIndex Update & Long-Term Growth Plans - newser.com

Nov 18, 2025

Nov 17, 2025

Analyzing Cognition Therapeutics Inc. with multi timeframe charts2025 Biggest Moves & Fast Moving Market Watchlists - newser.com

Nov 17, 2025

Nov 17, 2025

James M. O’Brien Appointed Chief Financial Officer at Mesoblast - GlobeNewswire Inc.

Nov 17, 2025

Nov 16, 2025

Cognition Therapeutics Announces $30.1M Direct Offering - MSN

Nov 16, 2025

Nov 16, 2025

Relative strength of Cognition Therapeutics Inc. in sector analysis2025 Stock Rankings & Community Consensus Stock Picks - newser.com

Nov 16, 2025

Nov 16, 2025

Will earnings trigger a reversal in Cognition Therapeutics Inc.July 2025 Technicals & Real-Time Volume Triggers - newser.com

Nov 16, 2025

Nov 15, 2025

Will Cognition Therapeutics Inc. stock benefit from upcoming earnings reports2025 Historical Comparison & Reliable Price Breakout Signals - newser.com

Nov 15, 2025

Nov 15, 2025

Smart tools for monitoring Cognition Therapeutics Inc.’s price actionTrade Ideas & Risk Controlled Swing Trade Alerts - newser.com

Nov 15, 2025

Nov 15, 2025

Is Cognition Therapeutics Inc. stock cheap at current valuationJuly 2025 Technicals & AI Driven Price Forecasts - newser.com

Nov 15, 2025

Nov 15, 2025

Will Cognition Therapeutics Inc. stock benefit from commodity pricesTrade Entry Report & Fast Exit and Entry Strategy Plans - newser.com

Nov 15, 2025

Nov 14, 2025

Why Cognition Therapeutics Inc. stock is a value investor pick2025 Bull vs Bear & Expert-Curated Trade Recommendations - newser.com

Nov 14, 2025

Nov 14, 2025

Published on: 2025-11-14 10:43:14 - Fundação Cultural do Pará

Nov 14, 2025

Nov 13, 2025

Cognition Therapeutics completes enrollment in Alzheimer’s drug trial By Investing.com - Investing.com Canada

Nov 13, 2025

Nov 13, 2025

Strategies to average down on Cognition Therapeutics Inc.July 2025 Breakouts & Verified Entry Point Signals - newser.com

Nov 13, 2025

Nov 13, 2025

Cognition Therapeutics Completes Enrollment in Phase 2 Study of Zervimesine in Early Alzheimer's Disease - MarketScreener

Nov 13, 2025

Nov 13, 2025

Cognition Therapeutics completes enrollment in Alzheimer’s drug trial - Investing.com

Nov 13, 2025

Nov 13, 2025

Cognition Therapeutics Announces Successful Enrollment in Phase 2 'START' Study for Zervimesine in Alzheimer’s Disease - Quiver Quantitative

Nov 13, 2025

Nov 13, 2025

Cognition Therapeutics Completes Enrollment in Phase 2 Study of Zervimesine (CT1812) in Early Alzheimer’s Disease - The Manila Times

Nov 13, 2025

Nov 13, 2025

Cognition (NASDAQ: CGTX) completes Phase 2 enrollment at 540; 15% on Leqembi or Kisunla - Stock Titan

Nov 13, 2025